Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000239
Aarion Gross, Robin A Barry
Abstract: Black and African American individuals continue to face a wide range of healthcare disparities compared with White non-Hispanic individuals. Research suggests that one effective way to improve health equity for Black people is to provide access to racially concordant healthcare providers-that is, Black patients receiving care from Black providers. This article briefly reviews the evidence showing that patient-provider racial concordance is associated with better outcomes for Black patients, indicating its potential in addressing health inequities. Despite this compelling evidence, many studies and population data reveal a persistent shortage of Black healthcare providers in the United States. Given the rapid growth and high demand for physician associates (PAs) in the United States, the PA profession is uniquely positioned to address this need. The article concludes with recommendations to increase diversity in the PA profession and broader healthcare workforce.
{"title":"Black and African American patient-provider racial concordance and health equity.","authors":"Aarion Gross, Robin A Barry","doi":"10.1097/01.JAA.0000000000000239","DOIUrl":"https://doi.org/10.1097/01.JAA.0000000000000239","url":null,"abstract":"<p><strong>Abstract: </strong>Black and African American individuals continue to face a wide range of healthcare disparities compared with White non-Hispanic individuals. Research suggests that one effective way to improve health equity for Black people is to provide access to racially concordant healthcare providers-that is, Black patients receiving care from Black providers. This article briefly reviews the evidence showing that patient-provider racial concordance is associated with better outcomes for Black patients, indicating its potential in addressing health inequities. Despite this compelling evidence, many studies and population data reveal a persistent shortage of Black healthcare providers in the United States. Given the rapid growth and high demand for physician associates (PAs) in the United States, the PA profession is uniquely positioned to address this need. The article concludes with recommendations to increase diversity in the PA profession and broader healthcare workforce.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":"38 11","pages":"e8-e11"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000265
Ethan Stonerook
{"title":"Where's home for you?","authors":"Ethan Stonerook","doi":"10.1097/01.JAA.0000000000000265","DOIUrl":"https://doi.org/10.1097/01.JAA.0000000000000265","url":null,"abstract":"","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":"38 11","pages":"50"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000263
Jaclyn M Demeter, Kevin Bogenschutz, Andrew Chastain
Abstract: Low back pain is among the most common conditions treated by physician associates in family medicine, internal medicine, and emergency medicine clinics. Inflammatory low back pain is the most frequent manifestation of axial spondyloarthritis (axSpA). AxSpA has a prevalence of 1.0% to 1.4% in the United States. The diagnosis of axSpA includes both clinical and radiographic components. With the advancement of biologic pharmacologic agents, the American College of Rheumatology, Spondylitis Association of America, and Spondyloarthritis Treatment Network have provided updated recommendations for the pharmacologic and nonpharmacologic management of axSpA. The recognition of axSpA and comorbid peripheral spondyloarthropathies is important, as the management of axSpA differs from routine musculoskeletal back pain. Treatment guidelines focus on symptom management, functionality, and disease progression.
{"title":"Diagnosis and management of axial spondyloarthritis.","authors":"Jaclyn M Demeter, Kevin Bogenschutz, Andrew Chastain","doi":"10.1097/01.JAA.0000000000000263","DOIUrl":"10.1097/01.JAA.0000000000000263","url":null,"abstract":"<p><strong>Abstract: </strong>Low back pain is among the most common conditions treated by physician associates in family medicine, internal medicine, and emergency medicine clinics. Inflammatory low back pain is the most frequent manifestation of axial spondyloarthritis (axSpA). AxSpA has a prevalence of 1.0% to 1.4% in the United States. The diagnosis of axSpA includes both clinical and radiographic components. With the advancement of biologic pharmacologic agents, the American College of Rheumatology, Spondylitis Association of America, and Spondyloarthritis Treatment Network have provided updated recommendations for the pharmacologic and nonpharmacologic management of axSpA. The recognition of axSpA and comorbid peripheral spondyloarthropathies is important, as the management of axSpA differs from routine musculoskeletal back pain. Treatment guidelines focus on symptom management, functionality, and disease progression.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":" ","pages":"22-28"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000264
Nick Entsminger
Objective: This pilot study assesses diagnostic agreement between correctional advanced practice providers (APPs) and physicians in interpreting 12-lead ECG results for STEMI diagnosis, with the aim of determining whether APPs offer comparable care to adult correctional populations that decreases ED burden.
Methods: This study compared the diagnostic accuracy of APPs with that of physicians in identifying STEMI through an online 12-lead ECG assessment based on current guideline criteria. Sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy were calculated for each profession. Unadjusted odds ratio (OR) with 95% CI were used to compare groups.
Results: Of the 37 total completed submissions, no statistically significant difference was observed in overall 12-lead ECG STEMI diagnostic accuracy among the groups.
Conclusions: Correctional APPs and physicians had comparable accuracy in using 12-lead ECGs to identify STEMI, and evaluation by an APP in the correctional setting does not increase the likelihood of ED evaluation. However, a quality improvement study entailing use of larger sample sizes and proctor-controlled assessments is needed to accurately determine APP 12-lead ECG STEMI competency.
{"title":"Agreement between APPs and physicians in interpreting 12-lead ECGs for STEMI in the correctional setting: An analysis.","authors":"Nick Entsminger","doi":"10.1097/01.JAA.0000000000000264","DOIUrl":"10.1097/01.JAA.0000000000000264","url":null,"abstract":"<p><strong>Objective: </strong>This pilot study assesses diagnostic agreement between correctional advanced practice providers (APPs) and physicians in interpreting 12-lead ECG results for STEMI diagnosis, with the aim of determining whether APPs offer comparable care to adult correctional populations that decreases ED burden.</p><p><strong>Methods: </strong>This study compared the diagnostic accuracy of APPs with that of physicians in identifying STEMI through an online 12-lead ECG assessment based on current guideline criteria. Sensitivity, specificity, positive predictive value, negative predictive value, and overall accuracy were calculated for each profession. Unadjusted odds ratio (OR) with 95% CI were used to compare groups.</p><p><strong>Results: </strong>Of the 37 total completed submissions, no statistically significant difference was observed in overall 12-lead ECG STEMI diagnostic accuracy among the groups.</p><p><strong>Conclusions: </strong>Correctional APPs and physicians had comparable accuracy in using 12-lead ECGs to identify STEMI, and evaluation by an APP in the correctional setting does not increase the likelihood of ED evaluation. However, a quality improvement study entailing use of larger sample sizes and proctor-controlled assessments is needed to accurately determine APP 12-lead ECG STEMI competency.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":" ","pages":"30-34"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000268
Alannah Zheng, Brittany Strelow
{"title":"What is causing this patient's vulvar ulcerations?","authors":"Alannah Zheng, Brittany Strelow","doi":"10.1097/01.JAA.0000000000000268","DOIUrl":"https://doi.org/10.1097/01.JAA.0000000000000268","url":null,"abstract":"","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":"38 11","pages":"45-47"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000273
Ashlyn Smith
Abstract: Every 3 seconds worldwide, a fracture due to osteoporosis occurs. Yet approximately 80% of individuals who have sustained a fragility fracture are not identified as having osteoporosis or treated for the condition. Many misconceptions and barriers plague care for this "silent" condition, contributing to a health care gap with catastrophic consequences. Importantly, clear guidance on screening, prevention, and treatment is available, paving the way for clinicians who are willing to "own the bone" and narrow the gap. Most recently, the US Preventive Services Task Force (USPSTF) published updated guidance for osteoporosis screening in early 2025. This guidance largely supports previous recommendations, strengthening the firm foundations clinicians use to address this critical need.
{"title":"An update on osteoporosis management and fracture prevention strategies.","authors":"Ashlyn Smith","doi":"10.1097/01.JAA.0000000000000273","DOIUrl":"10.1097/01.JAA.0000000000000273","url":null,"abstract":"<p><strong>Abstract: </strong>Every 3 seconds worldwide, a fracture due to osteoporosis occurs. Yet approximately 80% of individuals who have sustained a fragility fracture are not identified as having osteoporosis or treated for the condition. Many misconceptions and barriers plague care for this \"silent\" condition, contributing to a health care gap with catastrophic consequences. Importantly, clear guidance on screening, prevention, and treatment is available, paving the way for clinicians who are willing to \"own the bone\" and narrow the gap. Most recently, the US Preventive Services Task Force (USPSTF) published updated guidance for osteoporosis screening in early 2025. This guidance largely supports previous recommendations, strengthening the firm foundations clinicians use to address this critical need.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":" ","pages":"15-21"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000269
Chelsey Meachum
Abstract: Measles cases are increasing across the United States, with infants under age 12 months at increased risk as they are not yet eligible for routine measles, mumps, and rubella (MMR) vaccination. The current MMR vaccination schedule is based on decades-old data from an era of widespread natural maternal immunity and low measles prevalence. Today, most mothers have vaccine-derived immunity, and recent studies show these maternal antibodies wane by 3 to 6 months of age, leaving many infants vulnerable to infection until they receive their first MMR vaccine at the currently recommended age of 12 to 15 months. Evidence demonstrates, however, that MMR vaccination between ages 6 and 11 months provides partial protection during outbreaks and does not impair the immune response to later doses. Safety data also support vaccination in younger infants. Although early MMR vaccination is currently recommended before international travel, it should also be offered domestically during outbreaks as a risk-based strategy. National guidance should be updated to reflect current epidemiology and close this gap in infant protection.
{"title":"Early MMR vaccination during measles outbreaks: Reconsidering routine timing.","authors":"Chelsey Meachum","doi":"10.1097/01.JAA.0000000000000269","DOIUrl":"10.1097/01.JAA.0000000000000269","url":null,"abstract":"<p><strong>Abstract: </strong>Measles cases are increasing across the United States, with infants under age 12 months at increased risk as they are not yet eligible for routine measles, mumps, and rubella (MMR) vaccination. The current MMR vaccination schedule is based on decades-old data from an era of widespread natural maternal immunity and low measles prevalence. Today, most mothers have vaccine-derived immunity, and recent studies show these maternal antibodies wane by 3 to 6 months of age, leaving many infants vulnerable to infection until they receive their first MMR vaccine at the currently recommended age of 12 to 15 months. Evidence demonstrates, however, that MMR vaccination between ages 6 and 11 months provides partial protection during outbreaks and does not impair the immune response to later doses. Safety data also support vaccination in younger infants. Although early MMR vaccination is currently recommended before international travel, it should also be offered domestically during outbreaks as a risk-based strategy. National guidance should be updated to reflect current epidemiology and close this gap in infant protection.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":"38 11","pages":"39-42"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000270
Christina Krasnavage, Christopher Kudrich, Edwin Salsitz
Abstract: Xylazine is a veterinary drug that has become a common adulterant in opioids, particularly heroin and fentanyl. This article provides a comprehensive review of the drug, including its history, pharmacology, toxicology, pathophysiology, withdrawal, medical management, associated wound care, and harm reduction strategies, so that physician associates and other clinicians may be better equipped to recognize possible xylazine misuse in their patients and provide adequate treatment for xylazine-related harms.
{"title":"Beyond fentanyl: The emergence of xylazine in illicit opioids.","authors":"Christina Krasnavage, Christopher Kudrich, Edwin Salsitz","doi":"10.1097/01.JAA.0000000000000270","DOIUrl":"https://doi.org/10.1097/01.JAA.0000000000000270","url":null,"abstract":"<p><strong>Abstract: </strong>Xylazine is a veterinary drug that has become a common adulterant in opioids, particularly heroin and fentanyl. This article provides a comprehensive review of the drug, including its history, pharmacology, toxicology, pathophysiology, withdrawal, medical management, associated wound care, and harm reduction strategies, so that physician associates and other clinicians may be better equipped to recognize possible xylazine misuse in their patients and provide adequate treatment for xylazine-related harms.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":"38 11","pages":"35-38"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145379436","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-11-01Epub Date: 2025-10-28DOI: 10.1097/01.JAA.0000000000000266
Liam Allan, Sophie MacDonald, Sue Donaldson, Alastair Murray
Abstract: Physician associates (PAs) have featured among multidisciplinary care teams in the Scottish health care system for the last 19 years and have gradually become an established profession. Despite this, there remains no clear pathway for career progression for experienced PAs. This study used an original questionnaire, in addition to publicly available workforce and education data, to gain insight into the current education, deployment, and career development aspirations of this professional group in Scotland. The questionnaire was sent to all contactable PAs in Scotland before data were thematically analyzed.We found that Scottish PAs are experienced and keen to develop within the National Health Service Scotland workforce; however, they require a better career structure and improved support to allow them to work to their full potential. The establishment of a career progression framework, along with the infrastructure to support it, is urgently needed to support the development of this profession.
{"title":"PA profession in Scotland: Current landscape and future direction.","authors":"Liam Allan, Sophie MacDonald, Sue Donaldson, Alastair Murray","doi":"10.1097/01.JAA.0000000000000266","DOIUrl":"10.1097/01.JAA.0000000000000266","url":null,"abstract":"<p><strong>Abstract: </strong>Physician associates (PAs) have featured among multidisciplinary care teams in the Scottish health care system for the last 19 years and have gradually become an established profession. Despite this, there remains no clear pathway for career progression for experienced PAs. This study used an original questionnaire, in addition to publicly available workforce and education data, to gain insight into the current education, deployment, and career development aspirations of this professional group in Scotland. The questionnaire was sent to all contactable PAs in Scotland before data were thematically analyzed.We found that Scottish PAs are experienced and keen to develop within the National Health Service Scotland workforce; however, they require a better career structure and improved support to allow them to work to their full potential. The establishment of a career progression framework, along with the infrastructure to support it, is urgently needed to support the development of this profession.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":" ","pages":"e2-e7"},"PeriodicalIF":0.8,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-10-01Epub Date: 2025-09-25DOI: 10.1097/01.JAA.0000000000000252
Clay W Walker, Thomas Hartman, Brittney Hulsey
Abstract: Hemoptysis, defined as the expectoration of blood originating from the lower respiratory tract, is a clinical symptom with a wide differential diagnosis that ranges from benign to life-threatening causes. Common causes vary by geographic region and care setting, with respiratory infections, malignancy, bronchiectasis, and chronic obstructive pulmonary disease being predominant in resource-rich countries and tuberculosis remaining the leading cause in resource-limited areas. Though most cases are mild and self-limited, hemoptysis can be a life-threatening medical emergency; these cases are associated with a mortality exceeding 50%, primarily due to asphyxia. Management strategies are informed by severity, with outpatient care appropriate for stable patients with non-life-threatening hemoptysis and intensive interventions-such as bronchial artery embolization or surgical resection-reserved for those with high-risk features or life-threatening hemoptysis. This article provides an evidence-based approach to hemoptysis evaluation and management, emphasizing the importance of early risk stratification, identification of underlying causes, and timely intervention. By integrating a structured diagnostic and therapeutic approach, clinicians can improve outcomes and reduce the risk of recurrence and complications.
{"title":"Evaluation and management of hemoptysis.","authors":"Clay W Walker, Thomas Hartman, Brittney Hulsey","doi":"10.1097/01.JAA.0000000000000252","DOIUrl":"10.1097/01.JAA.0000000000000252","url":null,"abstract":"<p><strong>Abstract: </strong>Hemoptysis, defined as the expectoration of blood originating from the lower respiratory tract, is a clinical symptom with a wide differential diagnosis that ranges from benign to life-threatening causes. Common causes vary by geographic region and care setting, with respiratory infections, malignancy, bronchiectasis, and chronic obstructive pulmonary disease being predominant in resource-rich countries and tuberculosis remaining the leading cause in resource-limited areas. Though most cases are mild and self-limited, hemoptysis can be a life-threatening medical emergency; these cases are associated with a mortality exceeding 50%, primarily due to asphyxia. Management strategies are informed by severity, with outpatient care appropriate for stable patients with non-life-threatening hemoptysis and intensive interventions-such as bronchial artery embolization or surgical resection-reserved for those with high-risk features or life-threatening hemoptysis. This article provides an evidence-based approach to hemoptysis evaluation and management, emphasizing the importance of early risk stratification, identification of underlying causes, and timely intervention. By integrating a structured diagnostic and therapeutic approach, clinicians can improve outcomes and reduce the risk of recurrence and complications.</p>","PeriodicalId":48728,"journal":{"name":"Jaapa-Journal of the American Academy of Physician Assistants","volume":" ","pages":"17-22"},"PeriodicalIF":0.8,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145030323","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}